Global Aminoguanidine Bicarbonate Market Strategic Research Report

Scope of the Report

The global Aminoguanidine Bicarbonate market size is predicted to grow from US$ 52.58 million in 2025 to US$ 77.72 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

Aminoguanidine bicarbonate (CAS: 2582-30-1) is a fine chemical intermediate featuring both guanidino and hydrazino functional groups. Typically appearing as a white or off-white crystalline powder, it exhibits reducing properties and chemical reactivity, and is primarily used in the synthesis of pharmaceuticals, pesticides, dyes, photographic chemicals, and other nitrogen-containing heterocyclic compounds.

In terms of purity, mainstream industrial-grade aminoguanidine bicarbonate typically ranges from 98% to 99% and is used to synthesize intermediates for pharmaceuticals, pesticides, and dyes; high-purity or reagent-grade products are primarily used in laboratories, R&D, and pilot-scale trials, commanding higher unit prices but lower sales volumes.

The primary application of aminoguanidine bicarbonate is as an intermediate in pharmaceutical and chemical synthesis. In the pharmaceutical sector, it is used to synthesize compounds such as furaguanidine, pyrimipyrazole, ribavirin (via the intermediate 5-amino-1,2,4-triazole-3-carboxylic acid), and propamidine. Outside the pharmaceutical industry, it serves as a raw material for synthesizing pesticides, dyes, photographic chemicals, and blowing agents. The market landscape is dominated by pharmaceutical intermediates, supplemented by pesticide and dye applications, while photographic chemicals, blowing agents, and other organic synthesis uses account for a smaller share.

Market growth is driven primarily by the rising demand for pharmaceutical intermediates. Aminoguanidine bicarbonate is involved in the synthesis of various nitrogen-containing heterocycles, guanidines, and triazoles; its downstream applications span antiviral, hypoglycemic, and antibacterial drugs as well as active pesticide intermediates, thereby benefiting from growth in the pharmaceutical CDMO, generic drug, and specialty API supply chains. However, the market has limited capacity, low downstream concentration, and significant price volatility. Aminoguanidine bicarbonate is not a bulk commodity chemical; downstream procurement is typically order-based, resulting in high demand elasticity, and changes in synthesis pathways for specific pharmaceutical or pesticide intermediates can impact short-term demand.

Looking ahead, the market share of pharmaceutical-grade and high-purity aminoguanidine bicarbonate products is expected to rise as downstream customers demand stricter impurity control, stability, and batch-to-batch consistency, squeezing profit margins for low-end industrial products. Meanwhile, Chinese enterprises are likely to increase their export share, with markets in Europe, India, and Japan continuing to source stable, large-scale supplies from China.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Aminoguanidine Bicarbonate market?

What factors are driving Aminoguanidine Bicarbonate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Aminoguanidine Bicarbonate market opportunities vary by end market size?

How does Aminoguanidine Bicarbonate break out by Type, by Application?

This report presents a comprehensive overview of the global Aminoguanidine Bicarbonate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 98%≤Purity＜99%
• Purity≥99%
• Others

Segment by Application

• Pesticide
• Medicine
• Dye
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Aminoguanidine Bicarbonate market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pesticide, Medicine, Dye evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact